Nano X Imaging is expected to report a consensus revenue of $5.34 million and a loss per share of $0.15 for the third quarter, while the current stock price of approximately $0.32 remains significantly below the average analyst price target of $4.33.
Investors are primarily focused on the company’s liquidity position and 'going concern' status following preliminary results that warned of insufficient cash to fund operations for the next twelve months.
While the company saw a significant tenfold increase in AI and software solutions revenue to $1.0 million in its preliminary update, teleradiology services remained stagnant at $3.1 million. The reporting period follows a board-approved cost-reduction plan aiming for a 25-30% cut in global operating expenses by early 2027 to extend the firm's cash runway.